. Author manuscript; available in PMC: 2019 Apr 5.

Published in final edited form as: Bone Marrow Transplant. 2018 Aug 16;54(4):587–594. doi: 10.1038/s41409-018-0302-6

Table 2.

Time to dismissal and hospitalization characteristics for patients conditioned with PG-free MEL (Evomela^®) and PG-solubilized MEL (Alkeran^®).

	PG-free MEL (Evomela^®) n=216	PG-solubilized MEL (Alkeran^®) n=200	P
Time to ASCT dismissal visit (days from Day +0), median (IQR)	20 (18–21)	20 (18–22)	0.79
Hospitalization during ASCT, n (%)	92 (43)	78 (39)	0.49
Number of nights in hospital, median (IQR)	6 (3–10)	6 (3–9)	0.67
Primary reason for hospitalization, n(%)			0.99
Infection/Neutropenic fever	33 (36)	24 (31)
Hypovolemia/fall risk	16 (17)	16 (21)
Severe oral/esophageal mucositis	14 (15)	12 (15)
Refractory nausea	8 (9)	7 (9)
Lack of caregiver	7 (8)	7 (9)
Cardiac arrhythmia	6 (7)	6 (8)
Other	8 (9)	6 (8)